๐ฎ๐ณ India Daybook: ICICI Pru Life, Nuvoco Vistas Q4 Results; Lupin & Piramal Pharma in Focus
Published: 2026-04-14 07:15 IST | Category: Markets | Author: Abhi AI
๐ EARNINGS TODAY
(Note: Board meetings and results announcements proceed despite the market holiday)
- ICICI Prudential Life Insurance: The board is meeting today to approve Q4 and full-year FY26 financial results and consider a dividend recommendation.
- Nuvoco Vistas Corporation: The cement major is scheduled to announce its quarterly earnings for the period ended March 31, 2026.
- Anand Rathi Share & Stock Brokers: To consider and approve financial results along with a dividend declaration.
- Den Networks: Board meeting scheduled to review and approve the audited financial statements for the fourth quarter.
- Eimco Elecon (India): The company will report its Q4 results and consider a dividend for the financial year.
๐ REGULATORY & USFDA
(Pharma companies reported significant regulatory milestones leading into the holiday)
- Lupin: Received USFDA approval for its abbreviated new drug application (ANDA) for Dapagliflozin and Metformin Hydrochloride extended-release tablets, used in the treatment of diabetes.
- Piramal Pharma: The USFDA assigned "Voluntary Action Indicated" (VAI) status to the companyโs Lexington facility following a successful inspection, clearing the path for continued manufacturing.
- Torrent Pharma: Successfully concluded a USFDA inspection at its Gujarat manufacturing unit with "Zero Observations," reinforcing its compliance standing.
- Biocon: Received USFDA approval for Dapagliflozin tablets (5 mg and 10 mg) and has scheduled investor meetings in Singapore and Hong Kong this week.
๐ ACQUISITION & DIVESTMENT
- L&T: The company's real estate arm, L&T Realty, has acquired a 100% stake in International Green Spaces for โน1,123 crore to expand its footprint.
- Mahindra & Mahindra (M&M): Subsidiaries of the auto major are set to divest their entire 99.04% stake in Erkunt Foundry as part of a portfolio restructuring.
- Apollo Hospitals: The healthcare giant has increased its stake in Apollo Health and Lifestyle to 100%, making it a wholly-owned subsidiary after an investment of โน18.7 crore.
๐ CORPORATE ACTIONS & FUNDRAISING
- NHPC: The board is meeting today to consider a fundraising proposal; the company recently received approval for a major hydro project in Arunachal Pradesh.
- Muthoot Finance: Investors are tracking the stock following the announcement of its highest-ever interim dividend of โน30 per share.
- NECC Ltd: Board meeting today to consider an increase in authorized share capital to support future growth plans.
๐ BROKERAGE RADAR
- ACME Solar Holdings: HSBC has initiated coverage on the stock with a 'Buy' rating and a target price of โน350, citing a projected 2.7x increase in capacity over the next three years.
TAGS: India Daybook, Stocks in News, Corporate News, Stock Market, Company News
Tags: India Daybook Stocks in News Corporate News Stock Market Company News